CT-868
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Carmot Therapeutics, Inc · Phase 1 · Completed · Enrollment 32
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.